Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.
Media - Press Releases

Israel Taps SIGA Technologies' ST-246 to Combat Smallpox in Simulated Bioterror Attack

NEW YORK - SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens,  announced that it was contacted to arrange an emergency mock acquisition of its lead drug candidate and smallpox antiviral, ST-246 (Tecovirimat), by leading Israeli government health and defense officials. The mock acquisition was part of a simulated bioterror-related smallpox outbreak.
To see the complete text of this article, you need to buy a subscription. If you already have one, please log in.
Enjoy Unlimited Access to Tolerance.ca for less than 15 cents/day (CAD).


More
~ Conference, Oct. 16, 2024. The War Against the Past: Fighting for our History
~ SLAV - Robert Lepage's Reaction
~ Author and Tolerance.ca Editor, Victor Teboul, Ph.D., to speak at the Arab World Festival of Montreal
~ Oslo. Anders Behring Breivik's Video manifesto
~ Iran : Hey Ayatollah, Leave those kids alone! and Pink Floyd's remake
~ UN-backed group supports Somali Government’s peace overtures to rivals
~ Cargo vessel captured near Seychelles is commandeered to Somalia
~ U.S. and Oman Navy Rescue Indian Dhow from Somali Pirates - One Sailor Dead
~ Canada. 50% of tax filers participate in a private retirement savings plan
~ Somali Pirates capture second merchant vessel in 24h
Follow us on ...
Facebook Twitter
© 2024 Tolerance.ca® Inc. All reproduction rights reserved.

All information reproduced on the Web pages of www.tolerance.ca (including articles, images, photographs, and logos) is protected by intellectual property rights owned by Tolerance.ca® Inc. or, in certain cases, by its author. Any reproduction of the information for use other than personal use is prohibited. In particular, any alteration, widespread distribution, translation, sale, commercial exploitation or reutilization of the contents of the Web site, without the prior written permission of Tolerance.ca® Inc., is strictly forbidden. For information, please contact info@tolerance.ca

Tolerance.ca® Inc. is not responsible for external links nor for the contents of the advertisements appearing on Tolerance.ca®. Ads companies may use information about your visits to this web site in order to provide advertisements about goods and services of interest to you.
RSS